Biotechnological Hub of the NIB (BTH-NIB)

The purpose of the investment project BTH-NIB is the assurance of the appropriate infrastructural conditions for the use of research and developmental opportunities in the fields of operation of the NIB.

Play Video About project      Publication

Assist. Prof. Dr. Metka Novak

Working place: Scientific Associate

Telephone number: +386 (0)59 23 28 81
Department: Department of Genetic Toxicology and Cancer Biology

Scientific expertise

Cancer biochemistry; tumor microenvironment; cancer stem cells; chemokines; biomarkers; natural anti-cancer agents; 3D models for cancer research; new therapies in cancer treatment; brain cancer;



·         PhD (2014), Medical Faculty, PhD Program in Biomedicine, field: Biochemistry and Molecular Biology, University of Ljubljana, Slovenia

·         Bachelor degree in Biochemistry (2009), Faculty of Chemistry and Chemical Technology, field: Biochemistry, University of Ljubljana, Slovenia


2020-            Scientific Associate, National Institute of Biology, Department of Genetic Toxicology and Cancer Biology, Ljubljana, Slovenia

2018-2020    Research assistant, National Institute of Biology, Department of Genetic Toxicology and Cancer Biology, Ljubljana, Slovenia

2013-2017    Postdoc-Karolinska Institutet, Department of Oncology/Pathology, Karolinska  Biomics Center, Stockholm, Sweden

2009-2013    Junior Researcher – PhD candidate at the National Institute of Chemistry, Laboratory for Molecular Biology and Nanobiotechnology, Ljubljana, Slovenia (supervisor: Prof. Radovan Komel, PhD)

2011-2012    PhD research cooperation at Bohlmann lab, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada (supervisor: Prof. Joerg Bohlmann, PhD)

2007-2009    Research Associate at the National Institute of Chemistry, Laboratory for biosynthesis and biotransformation, Pharmaceutical Company Lek, d.d., Biopharmaceuticals, Recombinant Biotechnology, Ljubljana, Slovenia

Research projects

ARRS research programme P1-0245 »Ecotoxicology, toxicogenomics and carcinogenesis«, National Institute of biology, Ljubljana, Slovenia, PI prof. Tamara Lah Turnšek, webpage (2019-2024)

Project of European Programme of Cross-Border Cooperation for Slovenia-Italy (Interreg) TRANS-GLIOMA “New Therapies of glioblastoma based on cross-border translation research platform”, PI prof. Radovan Komel, Faculty of Medicine, University of Ljubljana, webpage:, (2017-2020)

Post-doctoral program founded by the Swedish Cancer Society. Analysis of Ephrin/Eph receptor signaling networks in lung cancer (2013-2017)

TRIA Project, Mountain Pine Beetle System Genomics, Vancouver, Canada 2011-2012

Cytochromes P450 from blue-stain fungi involved in monoterpene biotransformation (2009-2013)

Fungal cytochromes P450, involved in detoxification of plant defense compounds, as targets for new antifungal drugs (ARRS, J4-2212, 2009-2012)

Functional genomics and biotechnology for health (ARRS, P1-0104, 2009-2014)

The role of cytochrome P450 in mycotoxin biosynthesis and virulence of the pathogenic fungus Aspergillus fumigatus (ARRS, Z3 3660, 2010-2013)

 Teaching experineces

·         Elected assistant in the field of Biochemistry, Biotechnical Faculty, University of Ljubljana, Slovenia

·         Teacher of laboratory practical courses Cancer Biology at Biotechnical Faculty UL, Slovenia

·         Co-supervisor of bachelor’s, master’s  and PhD’s thesis



·         COBISS       




Member of the Slovenian Biochemical Society, member of IASLC (International Association for the Study of Lung Cancer), member of AACR (American Association for Cancer Research)